Torthaí cuardaigh - C. Oliver Hanemann
- 1 - 20 toradh as 44 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Magic but treatable? Tumours due to loss of Merlin de réir C. Oliver Hanemann
Foilsithe / Cruthaithe 2007Revisão -
2
Merlin, a multi‐suppressor from cell membrane to the nucleus de réir Lü Zhou, C. Oliver Hanemann
Foilsithe / Cruthaithe 2012Revisão -
3
Schwannomas and Their Pathogenesis de réir David A. Hilton, C. Oliver Hanemann
Foilsithe / Cruthaithe 2014Revisão -
4
-
5
Δ<sup>9</sup>‐tetrahydrocannabinol (Δ<sup>9</sup>‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease de réir Camille Carroll, Marie‐Louise Zeissler, C. Oliver Hanemann, John Zajicek
Foilsithe / Cruthaithe 2012Artigo -
6
Dissecting and Targeting the Growth Factor–Dependent and Growth Factor–Independent Extracellular Signal-Regulated Kinase Pathway in Human Schwannoma de réir Sylwia Ammoun, Christine Flaiz, Natalia Ristic, Jennifer Schuldt, C. Oliver Hanemann
Foilsithe / Cruthaithe 2008Artigo -
7
Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2 de réir Sylwia Ammoun, M. Caroline Schmid, J. Triner, Paul W. Manley, C. Oliver Hanemann
Foilsithe / Cruthaithe 2011Artigo -
8
Merlin-Deficient Human Tumors Show Loss of Contact Inhibition and Activation of Wnt/β-Catenin Signaling Linked to the PDGFR/Src and Rac/PAK Pathways de réir Lü Zhou, Emanuela Ercolano, Sylwia Ammoun, M. Caroline Schmid, Magdalena Barczyk, C. Oliver Hanemann
Foilsithe / Cruthaithe 2011Artigo -
9
Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2 de réir A.D Sperfeld, Claudine Hein, J. M. Schröder, Albert C. Ludolph, C. Oliver Hanemann
Foilsithe / Cruthaithe 2002Artigo -
10
Accumulation of autophagosomes confers cytotoxicity de réir Robert W. Button, Sheridan L. Roberts, Thea L. Willis, C. Oliver Hanemann, Shouqing Luo
Foilsithe / Cruthaithe 2017Artigo -
11
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis de réir Marie‐Louise Zeissler, Jordan Eastwood, Kieran McCorry, C. Oliver Hanemann, John Zajicek, Camille Carroll
Foilsithe / Cruthaithe 2016Artigo -
12
Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use de réir Chetan Bettegowda, Meena Upadhayaya, D. Gareth Evans, AeRang Kim, Dimitrios Mathios, C. Oliver Hanemann
Foilsithe / Cruthaithe 2021Artigo -
13
Artesunate induces necrotic cell death in schwannoma cells de réir Robert W. Button, Fang Lin, Emanuela Ercolano, Joseph H. Vincent, Bing Hu, C. Oliver Hanemann, Shouqing Luo
Foilsithe / Cruthaithe 2014Artigo -
14
Tumour-associated macrophage infiltration differs in meningioma genotypes, and is important in tumour dynamics de réir Ting Zhang, Claire Adams, György Fejér, Emanuela Ercolano, Jonathan Cutajar, Juri Na, Felix Sahm, C. Oliver Hanemann
Foilsithe / Cruthaithe 2025Artigo -
15
Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival de réir Sylwia Ammoun, Lucy Provenzano, Lü Zhou, Magdalena Barczyk, Kevin Gregory-Evans, David A. Hilton, Sassan Hafizi, C. Oliver Hanemann
Foilsithe / Cruthaithe 2013Artigo -
16
Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism de réir Jemma Dunn, Sara Ferluga, Vikram Sharma, Matthias E. Futschik, David A. Hilton, Claire Adams, Edwin Lasonder, C. Oliver Hanemann
Foilsithe / Cruthaithe 2018Artigo -
17
Tetracycline-inducible transgene expression mediated by a single AAV vector de réir A. Chtarto, Hans‐Ulrich Bender, C. Oliver Hanemann, Tim J. Kemp, Enni Lehtonen, Marc Levivier, Jacques Brotchi, Thierry Velu, Liliane Tenenbaum
Foilsithe / Cruthaithe 2003Artigo -
18
ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma de réir Sylwia Ammoun, Clare H. Cunliffe, Jeffrey C. Allen, Luis Chiriboga, Filippo G. Giancotti, David Zagzag, C. Oliver Hanemann, Matthias A. Karajannis
Foilsithe / Cruthaithe 2010Artigo -
19
Achieving consensus for clinical trials de réir Scott R. Plotkin, Jaishri O. Blakeley, Eva Dombi, Michael J. Fisher, C. Oliver Hanemann, Karin S. Walsh, Pamela L. Wolters, Brigitte C. Widemann
Foilsithe / Cruthaithe 2013Revisão -
20
Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus de réir Wei Li, Jonathan M. Cooper, Lü Zhou, Chenyi Yang, Hediye Erdjument‐Bromage, David Zagzag, Matija Snuderl, Marc Ladanyi, C. Oliver Hanemann, Pengbo Zhou, Matthias A. Karajannis, Filippo G. Giancotti
Foilsithe / Cruthaithe 2014Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Biology
Internal medicine
Pathology
Genetics
Neurofibromatosis
Cancer research
Cancer
Cell biology
Gene
Meningioma
Merlin (protein)
Neurofibromatosis type 2
Suppressor
Biochemistry
Clinical trial
Disease
Signal transduction
Bioinformatics
Receptor
Surgery
Amyotrophic lateral sclerosis
Chemistry
Computer science
Medical physics
Oncology
Pharmacology
Physical therapy
Radiology
Randomized controlled trial